ACHIEVE LIFE SCIENCES, INC. (CIK: 0000949858) EDGAR, Information, Filings... CompaniesBIO.Com

ACHIEVE LIFE SCIENCES, INC.

Mailing address
22722 29TH DR. SE, SUITE 100, SEATTLE, Delaware, 98021
Phone
425-686-1500
State location
Washington
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

ACHIEVE LIFE SCIENCES, INC. (CIK: 0000949858) is an American company incorporated in the state of Washington. Head office is located at 22722 29TH DR. SE, SUITE 100, SEATTLE, Washington, 98021. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. ACHIEVE LIFE SCIENCES, INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

ONCOGENEX PHARMACEUTICALS, INC. from 2008-21-Aug to 2017-31-Jul
SONUS PHARMACEUTICALS INC from 1996-24-May to 2008-07-Aug

Owner	Filings	Transaction Date	Type of Owner
KING THOMAS BRAXTON	0001279309	Mar-29-2023	director
Sellig Thomas	0001969416	Mar-29-2023	director
Duty Stuart	0001970274	Mar-29-2023	director
FICHTHORN JOHN	0001411509	Nov-18-2022	10 percent owner
DIALECTIC CAPITAL MANAGEMENT, LP	0001411512	Nov-18-2022	10 percent owner
Dialectic Partners, LLC	0001895109	Nov-18-2022	10 percent owner
Dialectic LS Manager LLC	0001955359	Nov-18-2022	10 percent owner
Dialectic Life Sciences SPV LLC	0001955360	Nov-18-2022	10 percent owner
HIMES VAUGHN B	0001361966	Mar-14-2022	director
SVB FINANCIAL GROUP	0000719739	Dec-22-2021	10 percent owner
SVB Innovation Credit Fund VIII, L.P.	0001754832	Dec-22-2021	10 percent owner
Innovation Credit Fund VIII-A, L.P.	0001864344	Dec-22-2021	10 percent owner
SVB Innovation Credit Partners VIII-A, LLC	0001901800	Dec-22-2021	10 percent owner
SVB Innovation Credit Partners VIII, LLC	0001901811	Dec-22-2021	10 percent owner
Martell Bridget A	0001629627	Mar-15-2021	director
Wann Jerry	0001828041	Sep-28-2020	officer: Principal Accounting Officer
ARMISTICE CAPITAL, LLC	0001601086	May-30-2019	10 percent owner
Armistice Capital Master Fund Ltd.	0001633584	May-30-2019	10 percent owner
Boyd Steven	0001706140	May-30-2019	10 percent owner
MOYES JAY M	0001191062	Aug-01-2017	director
Joseph Donald	0001319460	Aug-01-2017	director
Clarke Anthony	0001713368	Aug-01-2017	director, officer: Chief Scientific Officer
Stewart Richard Alistair	0001713369	Aug-01-2017	director, officer: President & CEO
Schacter Robert	0001714295	Aug-01-2017	10 percent owner
Bencich John	0001477056	Aug-11-2014	officer: CFO and PFO
Wyrick Susan D.	0001568605	Feb-01-2013	officer: PAO
Smith David V	0001229447	Aug-09-2010	director
MATTINGLY MARTIN A	0001265782	Jun-08-2010	director
PARKER H STEWART	0001217456	Mar-23-2010	director
GOLDSTEIN JACK	0001230729	Mar-23-2010	director
Lawrence Cameron William	0001486333	Feb-24-2010	officer: Principal Financial Officer
TAMER ANTHONY	0001050045	Aug-21-2008	10 percent owner
MNAYMNEH SAMI	0001050046	Aug-21-2008	10 percent owner
VENTURES WEST CAPITAL LTD	0001105940	Aug-21-2008	10 percent owner
JACOBS CINDY	0001229762	Aug-21-2008	officer: Exec. VP & Chief Med. Officer
Clendeninn Neil James	0001442443	Aug-21-2008	director
Anderson Stephen Charles	0001442674	Aug-21-2008	officer: CFO & Secretary
Cormack Scott Daniel	0001442675	Aug-21-2008	director, officer: President & CEO
Brady Patrick Robert	0001442772	Aug-21-2008	director
H.I.G. KEY CORP	0001443982	Aug-21-2008	10 percent owner
H.I.G. HORIZON CORP	0001444085	Aug-21-2008	10 percent owner
H.I.G. ONCOGENEX, INC.	0001444086	Aug-21-2008	10 percent owner
Eudy Craig Steven	0001383343	Jan-01-2005	officer: Principal Accounting Officer
MARTINO MICHAEL A	0001238250	Dec-29-2004	director, officer: President & CEO
STEWART MICHAEL B	0001238655	Dec-29-2004	officer: Sr. VP & Chief Medical Officer
Fuhrman Alan	0001303521	Sep-15-2004	officer: Senior Vice President & CFO
DUNBAR GEORGE W JR	0001194712	May-05-2004	director
BURRIS MICHELLE	0001229765	May-05-2004	director
WINSTEAD DWIGHT	0001244331	May-05-2004	director
COHEN STEVEN A/SAC CAPITAL MGMT LP	0000905226	Feb-19-2004	10 percent owner
S A C CAPITAL MANAGEMENT L L C	0001015076	Feb-19-2004	10 percent owner
SAC CAPITAL ASSOCIATES LLC	0001018101	Feb-19-2004	10 percent owner
SAC CAPITAL ADVISORS LLC	0001018103	Feb-19-2004	10 percent owner
SAC HEALTHCO FUND LLC	0001205928	Feb-19-2004	10 percent owner
KLEIN RICHARD J	0001238252	Dec-29-2003	officer: Senior V.P. & CFO
IVY ROBERT E	0001244341	Nov-10-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ACHIEVE LIFE SCIENCES, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001193125-24-207129 (34 Act) Size: KB	Aug-26-2024	033-80623 241241951
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-099091 ( Act) Size: 0 KB	Aug-20-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-099082 ( Act) Size: 0 KB	Aug-20-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-099074 ( Act) Size: 0 KB	Aug-20-2024
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-096193 (34 Act) Size: KB	Aug-13-2024	033-80623 241201459
8-K	Document	Current report filing Acc-no: 0000950170-24-096171 (34 Act) Size: KB	Aug-13-2024	033-80623 241201394
8-K	Document	Current report filing Acc-no: 0000950170-24-087118 (34 Act) Size: KB	Jul-29-2024	033-80623 241149025
EFFECT	Document	Acc-no: 9999999995-24-002096 (33 Act) Size: KB	Jul-08-2024	333-280585 241106243
UPLOAD	Document	Acc-no: 0000000000-24-007621 ( Act) Size: KB	Jul-03-2024	333-280585
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0000950170-24-081532 ( Act) Size: KB	Jul-03-2024
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0000950170-24-079095 (33 Act) Size: KB	Jun-28-2024	333-280585 241086214
8-K	Document	Current report filing Acc-no: 0000950170-24-078445 (34 Act) Size: KB	Jun-27-2024	033-80623 241079247
8-K	Document	Current report filing Acc-no: 0000950170-24-069973 (34 Act) Size: KB	Jun-06-2024	033-80623 241026352
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001013594-24-000500 (34 Act) Size: KB	May-20-2024	005-45969 24965520
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001829126-24-003471 (34 Act) Size: KB	May-17-2024	005-45969 24959124
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-056929 (34 Act) Size: KB	May-09-2024	033-80623 24930581
8-K	Document	Current report filing Acc-no: 0000950170-24-056876 (34 Act) Size: KB	May-09-2024	033-80623 24930407
EFFECT	Document	Acc-no: 9999999995-24-001397 (33 Act) Size: KB	May-06-2024	333-278961 24919413
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001193125-24-129355 ( Act) Size: KB	May-02-2024
UPLOAD	Document	Acc-no: 0000000000-24-004997 ( Act) Size: KB	May-02-2024	333-278961

Recent 20 filings. View all ACHIEVE LIFE SCIENCES, INC. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

ACHIEVE LIFE SCIENCES, INC. overview
ACHIEVE LIFE SCIENCES, INC. job
ACHIEVE LIFE SCIENCES, INC. stock
ACHIEVE LIFE SCIENCES, INC. ownership
ACHIEVE LIFE SCIENCES, INC. CEO
ACHIEVE LIFE SCIENCES, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.